Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma

Hiroyuki Takahashi, Hidenori Ojima, Hiroko Shimizu, Junji Furuse, Hiroyuki Furukawa, Tatsuhiro Shibata

Research output: Contribution to journalArticle

18 Citations (Scopus)

Fingerprint Dive into the research topics of 'Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences